Diabetes, metformin, and breast cancer in postmenopausal women
about
Metformin for endometrial hyperplasiaBiomarkers of cancer angioprevention for clinical studiesMetformin therapy and risk of cancer in patients with type 2 diabetes: systematic reviewAdherence to oral diabetes medications and glycemic control during and following breast cancer treatment.Obesity and cancer pathogenesis.Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data?Current strategies for the prevention of breast cancerMetformin and breast cancer stage at diagnosis: a population-based studyCARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysisThe quality control theory of aging.Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studiesAssociations among Metabolism, Circadian Rhythm and Age-Associated DiseasesModification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival.AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014.Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.Metformin in cancer prevention and therapy.Roles of tumor suppressors in regulating tumor-associated inflammation.Type 2 diabetes and mammographic breast density among underserved women.Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer.The effect of metformin on breast cancer outcomes in patients with type 2 diabetesMetformin and breast and gynecological cancer risk among women with diabetes.Reduction behavior induced by HL010183, a metformin derivative against the growth of cutaneous squamous cell carcinoma.Lack of effect of metformin on mammary carcinogenesis in nondiabetic rat and mouse models.Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index.Diabetes, diabetes treatment and breast cancer prognosis.Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant StressAssociations between diabetes medication use and risk of second breast cancer events and mortalityMetformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193bMetformin for endometrial hyperplasia: a Cochrane protocolAssociation between Metformin Therapy and Breast Cancer Incidence and Mortality: Evidence from a Meta-Analysis.Association of diabetes and diabetes treatment with incidence of breast cancer.Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer riskObesity, diabetes mellitus, and the risk of female breast cancer in Eastern China.Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30.Association between metformin therapy and mortality after breast cancer: a population-based study.Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients.Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.Effects of sulfonylureas on tumor growth: a review of the literature.
P2860
Q26472029-A06A6721-9C0D-43D4-A8E0-D6DF374DE20BQ26774580-7B6FE54F-7B05-4D60-8B54-4B8504714078Q26850912-AAC3AE3A-43F4-465B-9C8B-20D862EEAE6BQ27331637-E038B23A-EEF5-4881-9646-01E63099B281Q30361298-4A2F428F-C98A-484C-950F-FA76FA5AE699Q30572730-3F143B83-1619-4C31-BC21-2F504445291AQ33599463-2D3CFBD3-A93A-4722-98B8-54882959B45DQ33611185-468D8045-DBB6-46C0-B758-226D2A30D190Q33646525-47919B51-A1E1-49B1-B513-6B5D03C7490AQ33660253-3C6AF0EE-48EB-4358-B259-7D90AA54D484Q33688699-9C1E680C-A393-46FF-8170-4DF5BF5AE07BQ33714257-43D30730-F5D1-4340-A72B-98B9D5D8AA21Q33773047-35FB935E-714E-4901-B0A8-DA49DEDDF73DQ34042627-F6C313CD-301F-4D76-B184-4F0C6C2E6B4AQ34135248-725063D0-A01A-4EEB-94C2-3E07DF08454EQ34357983-A88ECC59-0DF0-4EEE-ABB3-091FDB05DF94Q34413441-D99470DA-A49D-4975-92C4-12C4D1548116Q34995690-C115EBD4-04D4-4830-8D38-047E725F17A6Q34998410-CDE308C0-6DF2-4DB0-B9A4-C80A2D8F2ED9Q35000522-137AD8AE-FC76-4CF6-BE18-A5572B25A3F7Q35046074-71D8ECA9-14EA-4647-8741-E71B91E16E8EQ35145204-67C88AEF-33C9-4FAF-9B69-B9BC755CB7FFQ35163721-07B3C366-FCFA-460D-826A-60A4F5A7EEACQ35186057-002B05C7-B500-4F8E-9B89-C622CE818B73Q35373602-346E576A-3B95-4FF2-9D64-E1F0FC010B2CQ35782187-9461A3D8-E7E0-4C86-85C3-95262A6046CAQ35850213-BC1ECAEA-262F-4823-9CCE-DD4EA59205F9Q36062114-FE3413CC-8424-4F7F-B284-2C0B0DDBCF6FQ36105494-260B4E26-A976-4D26-8577-BBB366179B31Q36145731-72F0B2BE-3B14-4432-9ECE-EBFAF8C85EF7Q36568614-53373A8B-5BE0-43BB-801F-0DF190D624F7Q36582700-EF80956E-488E-42AE-870B-A4D5DF067D9AQ36711193-21B80B04-F819-45A6-BDFB-E91A8F72F8E4Q36729549-7FEF1F57-55D1-4C67-AAC6-07C126B05A77Q36794283-8FA92C4F-4B4C-4F4D-A867-F81F35F17F8CQ36801172-3DFAADDF-67B1-41B7-8378-C0004C8B0A88Q37193432-494F2BC3-6978-4381-85F8-4D6C96FC6187Q37228018-0BF95E92-564F-4429-9646-D617F5286D62Q37228939-3A544799-9004-45E9-9764-28525EC2552DQ37247194-D5B7A04B-EDFC-4253-AB2F-10440CFF7BE2
P2860
Diabetes, metformin, and breast cancer in postmenopausal women
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diabetes, metformin, and breast cancer in postmenopausal women
@en
Diabetes, metformin, and breast cancer in postmenopausal women.
@nl
type
label
Diabetes, metformin, and breast cancer in postmenopausal women
@en
Diabetes, metformin, and breast cancer in postmenopausal women.
@nl
prefLabel
Diabetes, metformin, and breast cancer in postmenopausal women
@en
Diabetes, metformin, and breast cancer in postmenopausal women.
@nl
P2093
P2860
P356
P1476
Diabetes, metformin, and breast cancer in postmenopausal women
@en
P2093
Aaron K Aragaki
Anne McTiernan
David M Euhus
Howard Strickler
JoAnn E Manson
Karen Margolis
Lawrence S Phillips
Mara Vitolins
Marc Gunter
P2860
P304
P356
10.1200/JCO.2011.39.7505
P407
P577
2012-06-11T00:00:00Z